Fabrazyme

Fabrazyme

agalsidase beta

Manufacturer:

Genzyme

Distributor:

DKSH
Concise Prescribing Info
Contents
Agalsidase β
Indications/Uses
Fabry disease. Reduction of globotriaosylceramide (GL-3) deposition in capillary endothelium of kidney & certain other cell types.
Dosage/Direction for Use
Special Precautions
Life-threatening anaphylactic & severe allergic reactions. Infusion reactions. Closely monitor patients w/ compromised cardiac function. Immunogenicity. Appropriate medical support should be readily available. Pregnancy & lactation.
Adverse Reactions
Anaphylactic & allergic reactions. Infusion reactions, chills, pyrexia, feeling hot or cold, dyspnea, nausea, flushing, headache, vomiting, paresthesia, fatigue, pruritus, pain in extremity, HTN, chest pain, throat tightness, abdominal pain, dizziness, tachycardia, nasal congestion, diarrhea, peripheral edema, myalgia, back pain, pallor, bradycardia, urticaria, hypotension, face edema, rash, somnolence. Stroke, pain, ataxia, cardiac arrhythmia & arrest, decreased cardiac output, vertigo, hypoacousia, nephrotic syndrome. Immunogenicity.
ATC Classification
A16AB04 - agalsidase beta ; Belongs to the class of enzymes. Used in the treatment of alimentary tract and metabolism problems.
Presentation/Packing
Form
Fabrazyme powd for infusion 5 mg
Packing/Price
(single-use) 1's
Form
Fabrazyme powd for infusion 35 mg
Packing/Price
(single-use) 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in